Medical Cannabis Studies

A

• addiction (10)

• alzheimers/dementia (14)

• amyotrophic-lateral-sclerosis-als-lou-gehrigs (2)

• antibacterial (6)

• antioxidant (8)

• antiprion (1)

• anxiety (10)

• appetite (4)

• arthritis (4)

• asthma (1)

• attention-deficit-hyperactivity-disorder-adhd (5)

• autism (11)

• autoimmune (3)

B

• batten-disease (6)

• benefits (9)

• breast-cancer (7)

C

• cancer (94)

• cannabidiol-cbd (8)

• cardiovascular (8)

• cb1-receptor (8)

• cb2-receptor (9)

• cellular-function (4)

• cerebral-palsy (1)

• cognition (2)

• colon-cancer (8)

D

• d9-tetrahydrocannabinol-thc (4)

• d9-tetrahydrocannabinolic-acid-thca (1)

• diabetes (4)

• drug-interactions (2)

E

• emesis (6)

• endocannabinoid-system-ecs (45)

• endocrine-system (3)

• epilepsy (30)

F

• fibromyalgia (2)

• fibrosis (1)

G

• gastrointestinal-disease (6)

• general (20)

• glaucoma (1)

• glioblastoma (1)

• glioma (9)

H

• health-care (1)

• hiv (7)

• huntingtons-disease (1)

I

• immune-function (8)

• infant-development (1)

• inflammation (9)

• ischemia (3)

K

• krabbe-disease (4)

L

• liver (2)

• lung-cancer (2)

• lupus (1)

M

• memory (3)

• mental-illness (14)

• migraine (1)

• mitochondria (1)

• multiple-sclerosis (15)

N

• national-institute-on-drug-abuse-nida (1)

• nausea (1)

• nervous-system (4)

• neuro-protective-and-neuro-generative (7)

P

• pain (29)

• pancreatitis (1)

• prostate-cancer (2)

S

• schizophrenia (2)

• skin (1)

• sports (3)

T

• thc (1)

• therapeutic (1)

• traumatic-brain-injury-tbi (1)

• View All (505)
  • Cannabis and Cannabinoids (PDQ�): Health Professional Version (2019)

    In this PDQ summary, information on cancer was given to health professionals showing comprehensive, peer-reviewed and evidence-based information on the use of cannabis and cannabinoids in the treatment of people with cancer. View study

  • Cannabis and endocannabinoid modulators: Therapeutic promises and challenges (2005)

    This summary focuses on cannabis and endocannabinoid modulators and future therapeutic uses and challenges. The article examines the current understanding of CB1, CB2 and other possible cannabinoid receptors View study

  • Cannabis and the Health and Performance of the Elite Athlete (2018)

    Cannabis (marijuana) is undergoing extensive regulatory review in many global jurisdictions for medical and non-medical access. The purpose of this general review was to identify and highlight challenges in the interpretation of information regarding elite athletic performance, and to identify important areas of research that need to be addressed. It could be concluded that although cannabis use is more frequent in some athletes who practice high-risk sports, there is no direct evidence that athletes have direct effects on performance. View study

  • Cannabis as a substitute for alcohol and other drugs (2009)

    This study was conducted based on data collected in an anonymous survey to examine the use of alcohol and drugs, and the occurrence of substitution among medicinal cannabis patients. It was found that the reasons for the substitution were: fewer adverse side effects (65%), better management of symptoms (57%) and less potential for abstinence (34%) with cannabis. As a result of this study it was found that medicinal cannabis patients have been participating in the substitution using cannabis as an alternative to alcohol, prescriptions and illicit drugs. View study

  • Cannabis Extract Treatment for Terminal Acute Lymphoblastic Leukemia with a Philadelphia Chromosome Mutation (2013)

    Cannabinoids have antiproliferative and anti-inflammatory properties that can help fight cancer. In this case study, a treatment with scalable doses of cannabinoids was administered to a 14-year-old patient with acute lymphoblastic leukemia. The results indicate a certain level of control of the disease according to the dose of cannabinoids administered. However, more studies, research and laboratory tests are needed. View study

  • Cannabis for pediatric epilepsy: protocol for a living systematic review. (2018)

    Pediatric epilepsy, including treatment-resistant forms, has a greater effect on the quality of life, morbidity, and mortality of affected children. The present systematic revision will have the purpose of seeking, synthesizing, evaluating the published literature in order to provide usable and relevant information to parents, clinicians, and policy makers View study

  • Cannabis for schizophrenia (2014)

    Cannabidiol may have an antipsychotic effect in patients with schizophrenia. View study

  • Cannabis for therapeutic purposes and public health and safety: a systematic and critical review (2014)

    Critical analysis about the use of Cannabis for therapeutic purposes and its effects on health and public safety. View study

  • Cannabis improves symptoms of ADHD (2008)

    This research showed that some people with attention deficit / hyperactivity disorder (ADHD) that is related to lack of attention and an activated level of disturbance. They can benefit from the consumption of tetrahydrocannabinol (THC), and give them a better behavioral performance. View study

  • Cannabis in Cancer Care (2015)

    Numerous studies have shown that cannabinoids (active components of Cannabis sativa) can have positive effects in cancer treatment, in addition to alleviating the effects of attrition of chemotherapies, such as pain and loss of appetite. However, its medical use is limited due to its psychoactive effects and limited bioavailability. View study

  • Cannabis in painful HIV-associated sensory neuropathy (2007)

    This study focuses on cannabis in sensory neuropathy associated with painful HIV. The results show that the cannabis smoked by the patients was well tolerated and effectively alleviated the chronic neuropathic pain of sensory neuropathy associated with HIV. View study

  • Cannabis products for adults with chronic neuropathic pain (2018)

    View study